GlassScriptPhysician profile
Aila L Co
NPI 1487185187
$1,109.44
in general payments reported to CMS, 2019-2025
17 companies · $142 in 2025
The $142 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $24.04 · 2021: $337 · 2022: $172 · 2023: $411 · 2024: $22.88 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $576.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $279.96 | 2020-2022 | |
| Sanofi Pasteur INC. | $228.77 | 2021-2025 | |
| Corium, LLC | $192.51 | 2021-2023 | Azstarys |
| Cranial Technologies, INC | $102.51 | 2021-2023 | Doc Band |
| Kaleo, INC. | $45.38 | 2023 | Auvi-Q |
| Neos Therapeutics, LP | $36.14 | 2022-2023 | Adzenys Xr-Odt |
| Glaxosmithkline, LLC. | $35.35 | 2023 | Bexsero |
| Merck Sharp & Dohme LLC | $33.15 | 2023 | Gardasil 9, Vaxelis, Rotateq |
| Sobi, INC | $26.04 | 2023 | |
| Seqirus USA INC | $23.07 | 2023 | Flucelvax Quadrivalent |
| Pfizer INC. | $19.90 | 2023 | |
| Alk-Abello, INC | $19.37 | 2025 | Neffy |
| Teva Pharmaceuticals USA, INC. | $14.51 | 2021 | |
| Phadia US INC. | $14.50 | 2022 | |
| Nestle Healthcare Nutrition INC. | $13.78 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $13.38 | 2023 | |
| Ironshore Pharmaceuticals INC. | $11.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aila Co listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.